The Biological Intellectual Property Protection Act of 2025 restricts the export of synthetic DNA and RNA sequences to foreign entities of concern, primarily targeting China. The bill requires the Secretary of Commerce to establish a licensing system within one year to control exports of digital sequences of human-designed or AI-generated synthetic DNA or RNA to governments and companies associated with countries deemed a threat to U.S. national security. The legislation affects biotechnology companies, research institutions, and any organization that develops or transfers synthetic biological sequences internationally. The bill frames the restriction as a national security measure, citing concerns that China systematically acquires U.S. intellectual property through military-civilian fusion strategies and Chinese laws that compel citizens and companies to cooperate with state security priorities. No specific funding is allocated in the text, but the Commerce Department will be tasked with implementing and enforcing the licensing requirement.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.